Primary Site >> Stomach Cancer
Gene >> SLC44A4
|
|---|
|
Ref: A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers. PMID: 26994014 |
|
|---|
|
Ref: A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers. PMID: 26994014 |